Tissue-Based Testing

News on immunohistochemistry and other tissue-based testing methods.

According to the researchers, the method could enable higher-throughput analyses while removing some of the subjectivity inherent in pathology practice.

The firms launched OptraScan's Global TelePath Network in the UAE, India, and South Africa under the partnership, named Neuberg Digipath, Powered by OptraScan.

The test uses multiplex PCR fragment analysis with Promega-designed five-mononucleotide repeat markers to detect the MSI-high phenotype within tumor tissues.

A US expansion was logical because "there is high recognition [here] of the value that diagnostics can bring to the patient and to the oncologist," its CEO said.

AmoyDx's kit is designed to detect hotspot mutations/fusions in nine genes to help guide treatment decisions for non-small cell lung cancer patients.